公司资料
Vaxxinity 股价、新闻与催化剂
- 股票代码:
- VAXX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (-99.61%)
收盘价
最后更新: 2026年8月17日
—
市值
股价为何变动
As of Aug 17, 2026, VAXX closed down 99.6% at $0.0001. No new same-company headline was identified in the current news window.
公司概览
业务概览
Vaxxinity was a vaccine and immunotherapy company focused on synthetic vaccine development before its business was wound down and restructured. Its story reflected the challenge of translating platform ambition into commercial value.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, Vaxxinity sat in vaccine biotechnology.
商业模式特征
The business depended on platform validation, clinical progress, and investor patience for a long-duration vaccine story.
生物医药行业定位
Vaxxinity is best treated as a historical vaccine-platform case rather than a live catalyst leader.
未来催化剂
- Vaxxinity’s catalysts are its vaccine platform and any strategic update that clarifies the company’s next direction. The stock needs a clearer answer on how the platform becomes value-generating.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。